The Rubella vaccine is a crucial preventive measure against rubella, also known as German measles. Rubella is caused by the rubella virus, and while it generally causes a mild illness in children and adults, it poses significant risks to pregnant women. If a pregnant woman contracts rubella, it can lead to congenital rubella syndrome (CRS), resulting in severe birth defects in the developing fetus. The rubella vaccine is typically administered as part of the measles, mumps, and rubella (MMR) vaccine, providing immunity against all three diseases. It is also available in combination with the varicella (chickenpox) vaccine in the MMRV vaccine. Vaccination efforts, particularly in childhood, have led to a substantial decrease in rubella cases globally and have played a pivotal role in preventing CRS. The vaccine is generally well-tolerated, and widespread immunization is a key strategy in public health initiatives to eliminate rubella and protect vulnerable populations. Ongoing research continues to refine vaccine strategies, monitor vaccine safety, and improve global vaccination coverage against rubella.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan